The loop-mediated isothermal amplification (LAMP) assay detecting the slpA gene of slpA sequence type gc8 (slpA-gc8) was established for the identification of a hypervirulent Clostridium difficile strain, PCR ribotype 027. Of 107 isolates examined, 27 belonging to PCR ribotype 027 were all positive for the LAMP assay. The remaining 80 isolates were typed into 47 different PCR ribotypes other than type 027, and were negative for the LAMP assay with the exception of two isolates. The sensitivity and specificity of the LAMP method for identification of PCR ribotype 027 were 100 % and 98 %, respectively. The LAMP assay detecting slpA-gc8 is a reliable tool for the identification of PCR ribotype 027 C. difficile. This simple and rapid method will contribute to detection of the hypervirulent strain.
BarbutF.,
MastrantonioP.,
DelméeM.,
BrazierJ.,
KuijperE.,
PoxtonI.on behalf of the European Study Group on Clostridium difficile (ESGCD)2007; Prospective study of Clostridium difficile infections in Europe with phenotypic and genotypic characterisation of the isolates. Clin Microbiol Infect 13:1048–1057 [View Article][PubMed]
BraunV.,
HundsbergerT.,
LeukelP.,
SauerbornM.,
von Eichel-StreiberC.1996; Definition of the single integration site of the pathogenicity locus in Clostridium difficile
. Gene 181:29–38 [View Article][PubMed]
DelméeM.,
LarocheY.,
AvesaniV.,
CornelisG.1986; Comparison of serogrouping and polyacrylamide gel electrophoresis for typing Clostridium difficile
. J Clin Microbiol 24:991–994[PubMed]
GerdingD. N.2010; Global epidemiology of Clostridium difficile infection in 2010. Infect Control Hosp Epidemiol 31:Suppl. 1S32–S34 [View Article][PubMed]
GoorhuisA.,
Van der KooiT.,
VaessenN.,
DekkerF. W.,
Van den BergR.,
HarmanusC.,
van den HofS.,
NotermansD. W.,
KuijperE. J.2007; Spread and epidemiology of Clostridium difficile polymerase chain reaction ribotype 027/toxinotype III in The Netherlands. Clin Infect Dis 45:695–703 [View Article][PubMed]
GoorhuisA.,
BakkerD.,
CorverJ.,
DebastS. B.,
HarmanusC.,
NotermansD. W.,
BergwerffA. A.,
DekkerF. W.,
KuijperE. J.2008; Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078. Clin Infect Dis 47:1162–1170 [View Article][PubMed]
KatoH.,
KatoN.,
KatowS.,
MaegawaT.,
NakamuraS.,
LyerlyD. M.1999; Deletions in the repeating sequences of the toxin A gene of toxin A-negative, toxin B-positive Clostridium difficile strains. FEMS Microbiol Lett 175:197–203 [View Article][PubMed]
KatoH.,
YokoyamaT.,
KatoH.,
ArakawaY.2005; Rapid and simple method for detecting the toxin B gene of Clostridium difficile in stool specimens by loop-mediated isothermal amplification. J Clin Microbiol 43:6108–6112 [View Article][PubMed]
KatoH.,
ItoY.,
van den BergR. J.,
KuijperE. J.,
ArakawaY.2007; First isolation of Clostridium difficile 027 in Japan. Euro Surveill 12:E070111–E070113[PubMed]
KatoH.,
KatoH.,
ItoY.,
AkahaneT.,
IzumidaS.,
YokoyamaT.,
KajiC.,
ArakawaY.2010; Typing of Clostridium difficile isolates endemic in Japan by sequencing of slpA and its application to direct typing. J Med Microbiol 59:556–562 [View Article][PubMed]
KuijperE. J.,
BarbutF.,
BrazierJ. S.,
KleinkaufN.,
EckmannsT.,
LambertM. L.,
DrudyD.,
FitzpatrickF.,
WiuffC. et al.2008; Update of Clostridium difficile infection due to PCR ribotype 027 in Europe, 2008. Euro Surveill 13:433–439[PubMed]
LooV. G.,
PoirierL.,
MillerM. A.,
OughtonM.,
LibmanM. D.,
MichaudS.,
BourgaultA. M.,
NguyenT.,
FrenetteC. et al.2005; A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 353:2442–2449 [View Article][PubMed]
LyerlyD. M.,
BarrosoL. A.,
WilkinsT. D.,
DepitreC.,
CorthierG.1992; Characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile
. Infect Immun 60:4633–4639[PubMed]
PépinJ.,
ValiquetteL.,
AlaryM. E.,
VillemureP.,
PelletierA.,
ForgetK.,
PépinK.,
ChouinardD.2004; Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. CMAJ 171:466–472[PubMed][CrossRef]
RupnikM.,
AvesaniV.,
JancM.,
von Eichel-StreiberC.,
DelméeM.1998; A novel toxinotyping scheme and correlation of toxinotypes with serogroups of Clostridium difficile isolates. J Clin Microbiol 36:2240–2247[PubMed]
SawabeE.,
KatoH.,
OsawaK.,
ChidaT.,
TojoN.,
ArakawaY.,
OkamuraN.2007; Molecular analysis of Clostridium difficile at a university teaching hospital in Japan: a shift in the predominant type over a five-year period. Eur J Clin Microbiol Infect Dis 26:695–703 [View Article][PubMed]
SpigagliaP.,
MastrantonioP.2002; Molecular analysis of the pathogenicity locus and polymorphism in the putative negative regulator of toxin production (TcdC) among Clostridium difficile clinical isolates. J Clin Microbiol 40:3470–3475 [View Article][PubMed]
StubbsS. L.,
BrazierJ. S.,
O’NeillG. L.,
DuerdenB. I.1999; PCR targeted to the 16S-23S rRNA gene intergenic spacer region of Clostridium difficile and construction of a library consisting of 116 different PCR ribotypes. J Clin Microbiol 37:461–463[PubMed]
StubbsS.,
RupnikM.,
GibertM.,
BrazierJ.,
DuerdenB.,
PopoffM.2000; Production of actin-specific ADP-ribosyltransferase (binary toxin) by strains of Clostridium difficile
. FEMS Microbiol Lett 186:307–312 [View Article][PubMed]
WarnyM.,
PépinJ.,
FangA.,
KillgoreG.,
ThompsonA.,
BrazierJ.,
FrostE.,
McDonaldL. C.2005; Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 366:1079–1084 [View Article][PubMed]